These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12798746)

  • 21. Routine breast screening for women aged 65-69: results from evaluation of the demonstration sites.
    Moss SM; Brown J; Garvican L; Coleman DA; Johns LE; Blanks RG; Rubin G; Oswald J; Page A; Evans A; Gamble P; Wilson R; Lee L; Liston J; Sturdy L; Sutton G; Wardman G; Patnick J; Winder R
    Br J Cancer; 2001 Nov; 85(9):1289-94. PubMed ID: 11720462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Scottish breast screening programme's experience of monitoring interval cancers.
    Everington D; Gilbert FJ; Tyack C; Warner J
    J Med Screen; 1999; 6(1):21-7. PubMed ID: 10321366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
    Hoff SR; Klepp O; Hofvind S
    J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997.
    Autier P; Shannoun F; Scharpantgen A; Lux C; Back C; Severi G; Steil S; Hansen-Koenig D
    Int J Cancer; 2002 Feb; 97(6):828-32. PubMed ID: 11857363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    McVeigh TP; Wiggins J; Ward S; Kemp Z; George AJ
    Clin Breast Cancer; 2018 Aug; 18(4):282-288. PubMed ID: 29191429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many?
    Faux AM; Richardson DC; Lawrence GM; Wheaton ME; Wallis MG
    J Med Screen; 1997; 4(3):169-73. PubMed ID: 9368875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer following augmentation mammoplasty (United States).
    Brinton LA; Lubin JH; Burich MC; Colton T; Brown SL; Hoover RN
    Cancer Causes Control; 2000 Oct; 11(9):819-27. PubMed ID: 11075871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies.
    Lavigne E; Holowaty EJ; Pan SY; Villeneuve PJ; Johnson KC; Fergusson DA; Morrison H; Brisson J
    BMJ; 2013 Apr; 346():f2399. PubMed ID: 23637132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
    Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M
    J Med Screen; 2002; 9(2):74-82. PubMed ID: 12133927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening outcomes in women over age 70 who self-refer in the NHSBSP in England.
    Bennett RL; Moss SM
    J Med Screen; 2011; 18(2):91-5. PubMed ID: 21852702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.
    Woodman CB; Threlfall AG; Boggis CR; Prior P
    BMJ; 1995 Jan; 310(6974):224-6. PubMed ID: 7866124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of women at high genetic risk of breast cancer through the National Health Service Breast Screening Programme (NHSBSP).
    de Silva D; Gilbert F; Needham G; Deans H; Turnpenny P; Haites N
    J Med Genet; 1995 Nov; 32(11):862-6. PubMed ID: 8592328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
    Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
    BMJ; 1998 Aug; 317(7155):376-9. PubMed ID: 9694752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996-2001.
    Sauven P; Bishop H; Patnick J; Walton J; Wheeler E; Lawrence G; ;
    Br J Surg; 2003 Jan; 90(1):82-7. PubMed ID: 12520580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Breast complaints during the Dutch nationwide breast cancer screening program: increased risk of referral and of breast cancer].
    van Bon-Martens MJ; Klingenberg H; Dijkstra HA; Peeters PH
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1067-71. PubMed ID: 11414168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.